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o test the hypothesis that keratinocyte (KC) migration
is modulated by distinct muscarinic acetylcholine
(ACh) receptor subtypes, we inactivated signaling
through speciﬁc receptors in in vitro and in vivo models of
reepithelialization by subtype-selective antagonists, small
interfering RNA, and gene knockout in mice. KC migration
and wound reepithelialization were facilitated by M
 
4 
 
and
inhibited by M
 
3
 
. Additional studies showed that M
 
4 
 
increases
expression of “migratory” integrins 
 
 
 
5
 
 
 
1
 
, 
 
 
 
V
 
 
 
5
 
, and 
 
 
 
V
 
 
 
6
 
,
whereas M
 
3 
 
up-regulates “sedentary” integrins 
 
 
 
2
 
 
 
1 
 
and
 
 
 
3
 
 
 
1
 
. Inhibition of migration by M
 
3 
 
was mediated through
T
 
Ca
 
2
 
 
 
-dependent guanylyl cyclase–cyclic GMP–protein kinase
G signaling pathway. The M
 
4 
 
effects resulted from inhibition
of the inhibitory pathway involving the adenylyl cyclase–
cyclic AMP–protein kinase A pathway. Both signaling path-
ways intersected at Rho, indicating that Rho kinase provides
a common effector for M
 
3 
 
and M
 
4 
 
regulation of cell migration.
These ﬁndings offer novel insights into the mechanisms of
ACh-mediated modulation of KC migration and wound
reepithelialization, and may aid the development of novel
methods to promote wound healing.
 
Introduction
 
Cell migration is an essential step during normal and invasive
growth. Proper regulation of the crawling locomotion of
epithelial cells is critical during reepithelialization of skin
wounds (Donaldson and Mahan, 1988). To cover the defect,
keratinocytes (KCs), the stratified squamous epithelial cells
comprising the epidermis, migrate laterally over the de-
nuded dermis a few hours after wounding, and then differ-
entiate, forming a new epidermis. KCs are thought to migrate
both individually and as a cellular sheet (Donaldson and
Mahan, 1988). The speed of locomotion of human KCs
migrating as a sheet is 
 
 
 
0.4 
 
 
 
m/min (Grando et al.,
1993b). Different integrins mediate different types of inter-
actions of KCs with the ECM. To attach to fibronectin,
vitronectin, thrombospondin, and other proteins comprising
the provisional matrix, crawling KCs express the 
 
 
 
5
 
 
 
1
 
, 
 
 
 
V
 
 
 
5
 
,
and 
 
 
 
V
 
 
 
6 
 
integrins (Larjava et al., 1993). In contrast, the
 
 
 
2
 
 
 
1 
 
and 
 
 
 
3
 
 
 
1 
 
integrins are present at the sites of cell–cell
contacts (Marchisio et al., 1991). Thus, based on their
differential expression in wounded versus intact epidermis
and their relationship to KC migration, the integrin proteins
expressed by KCs can be tentatively divided into two groups:
“sedentary,” or nonmotile (
 
 
 
2 
 
and 
 
 
 
3
 
), versus “migratory,”
or motile (
 
 
 
5
 
, 
 
 
 
v
 
, and 
 
 
 
5
 
) integrins. Wound KCs also express
 
 
 
9 integrin, which is not maintained in cultured KCs under
standard conditions (Stepp et al., 2002).
To characterize the physiologic control of crawling loco-
motion of KCs, we developed an in vitro model of skin reep-
ithelialization, termed agarose gel KC outgrowth system
(AGKOS), which allows accurate evaluation of effects of
pharmacologic compounds on lateral migration of KCs
(Grando et al., 1993b). AGKOS measures a large cell popu-
lation response (
 
 
 
50,000 cells) in a milieu that approximates
a physiologic one because KCs move over the ECM proteins
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produced and deposited on the dish surface by KCs during
long-term incubations (Nickoloff et al., 1988; Marchisio et
al., 1991). A shorter, 24-h assay that allows study of the ini-
tiation of KC outgrowth is a “scratch assay” (Savani et al.,
1995). Compared with the AGKOS assay, it measures mi-
gration of a smaller, yet representative number of cells, i.e.,
up to 300 per a microscopic field at the magnification of 10.
Using AGKOS, we demonstrated that acetylcholine (ACh)
is required to initiate outgrowth of KCs in vitro and that cho-
linergic drugs have profound effects on the motility of these
cells (Grando et al., 1995; Zia et al., 2000). Human KCs
functionally synthesize, store, release, and degrade ACh both
in vivo and in vitro (Grando et al., 1993c). In the intact epi-
dermis, KCs constantly move along an upward concentration
gradient of ACh (Nguyen et al., 2001). The effects of ACh
on cell motility are complex and include both stimulatory
and inhibitory pathways regulating crawling locomotion
(Zheng et al., 1994; Clancy and Abramson, 2000). Recent
results strongly suggest that many of these effects are medi-
ated by members of the muscarinic ACh receptor (mAChR)
family (Varker and Williams, 2002; Chernyavsky et al.,
2003). The mAChRs are prototypical members of the super-
family of G protein–coupled receptors (GPCRs; Caulfield,
1993; Wess, 1996). The M
 
1
 
, M
 
3
 
, and M
 
5 
 
mAChRs are pref-
erentially coupled to activation of pertussis toxin–insensitive
G proteins of the G
 
 
 
q/11 
 
family and stimulate phospholipase
C, with resulting activation of PKC and the release of Ca
 
2
 
 
 
from intracellular stores. The other two mAChR subtypes,
M
 
2 
 
and M
 
4
 
, are selectively coupled to pertussis toxin–sensi-
tive G proteins of the G
 
i/o 
 
class and mediate the inhibition of
adenylyl cyclase (AC) activity and the activation of inward
rectifier K
 
  
 
channels. Stimulation of the M
 
3 
 
mAChR has
been shown to up-regulate the binding activity of 
 
 
 
1 
 
integrin,
which is associated with increased cell adhesion to ECM pro-
teins (Quigley et al., 1998; Williams, 2003) and inhibited
cell migration (Varker and Williams, 2002). Although G
 
i 
 
sig-
naling also alters integrin activity/expression, it leads to an
up-regulated cell migration (Wang et al., 1999). Signaling
from both G
 
 
 
q/11
 
-
 
 
 
and G
 
 
 
i/o
 
-coupled mAChRs alters activity
of the effector proteins of Rho family, with subsequent alter-
ations in the Rho-associated protein kinase (ROK) activity
(Harhammer et al., 1996). It has been demonstrated that the
Rho family GTPases are essential downstream elements in
the signaling pathway, linking mAChR stimulation to regula-
tion of cell motility (Linseman et al., 2000).
The purpose of this study was to explore the role of KC M
 
3
 
and M
 
4 
 
mAChRs in regulating KC migratory function and
elucidate the responsible mechanism(s). We used a combina-
tion of three overlapping approaches to inhibit mAChR-cou-
pled signaling pathways: (1) pharmacologic blockade with
receptor antagonist and regulatory enzyme inhibitors; (2)
mAChR gene silencing with small interfering RNA (siRNA);
and (3) mAChR gene knockout (KO) in mice. We found
that ACh stimulates the crawling locomotion of KCs by acti-
vating M
 
4 
 
receptors, but inhibits this activity through stimu-
lation of M
 
3 
 
receptors. The M
 
3 
 
effects were mediated through
the intracellular Ca
 
2
 
 
 
-dependent guanylyl cyclase (GC)–
cyclic GMP (cGMP)–protein kinase G (PKG) signaling up-
stream from the Rho–ROK pathway. The M
 
4 
 
effects resulted
from inhibition of the inhibitory pathway AC–cAMP–pro-
Figure 1. In vitro experiments with anti-
mAChR siRNA. (A) Representative results 
of Western blot analysis of the effects of 
siRNA-M3 and siRNA-M4 on M3 and M4 
mAChR expression in human KCs transfected 
with anti-mAChR siRNAs or negative control 
(NC) siRNA. On the third day after trans-
fection, the cellular proteins were analyzed 
by Western blotting. The results were com-
pared with those obtained with control (C) 
KCs exposed to TransIT-TKO (Mirus Corp.) 
transfection reagent mixed in Opti-MEM 
medium (GIBCO BRL) alone. The numbers 
underneath the bands are ratios of the den-
sitometry value of each mAChR receptor to 
that of  -actin compared with the values 
obtained in control KCs (taken as 1). (B) IF 
analysis of the effects of anti-M3 and anti-M4 
siRNAs on the expression of the M3 and M4 
mAChR subtypes on the cell membrane of 
human KCs. The cells were cultured and 
treated with the siRNA-M3 (black bars), 
siRNA-M4 (white bars), or negative control 
siRNA (not depicted) as described in A, 
fixed to avoid cell membrane permeabil-
ization, and stained with anti-M3 or anti-M4 
antibodies. (C) Dose-dependent effects of 
receptor-selective siRNA on KC migration. 
Second passage human KCs were loaded 
into AGKOS plates, transfected with 1.2, 
12, or 120 nM of negative control M3 or M4 siRNA, or exposed to TransIT-TKO transfection reagent mixed in Opti-MEM medium alone (control), 
and then used in AGKOS assay. (D) Opposing alterations in KC crawling locomotion due to M3 and M4 receptor gene silencing. (B–D) Asterisk 
indicates significant (P   0.05) differences from untreated control. NC, negative control siRNA. 
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tein kinase A (PKA). The opposing mechanistic effects of M
 
3
 
and M
 
4 
 
were accompanied by their reciprocal actions on the
expression levels of specific integrins. These findings may aid
the development of novel muscarinic drugs that are useful in
facilitating wound healing.
 
Results
 
Effects of mAChR subtype–selective siRNA on the 
migration distances of human KCs
 
Transfection with anti-M
 
3 
 
siRNA decreased the relative
amount of M
 
3 
 
receptor protein by 
 
 
 
83% without altering
M
 
4 
 
receptor expression and, vice versa, the anti-M
 
4 
 
siRNA
decreased the amount of M
 
4 
 
receptor protein by 
 
 
 
88%
without affecting M
 
3 
 
receptor expression (Fig. 1 A). Very
similar findings were obtained in semiquantitative immuno-
fluorescence (IF) assays (Fig. 1 B).
The siRNA-M
 
4 
 
significantly (P 
 
  
 
0.05) decreased and the
siRNA-M
 
3 
 
significantly (P 
 
  
 
0.05) increased KC migration
distance in a dose-dependent manner compared with that
exhibited by KCs treated with negative control siRNA se-
quences (Fig. 1 C). The enhanced migration of siRNA-M
 
3
 
–
treated KCs could be inhibited when the cells were fed with
serum-free KC growth medium (KGM) containing 10 nM
of the M
 
4
 
-preferring antagonist MT3. Conversely, the in-
hibited migration of the siRNA-M
 
4
 
–treated KCs could be
prevented in the presence of 10 nM 4-DAMP, which blocks
M
 
3 
 
receptors as well as other mAChR subtypes with high af-
finity (Dorje et al., 1991; Fig. 1 D).
When given alone, 10 nM MT3 reduced the migration
distance of cultured human KCs by 
 
 
 
50% (P 
 
  
 
0.05),
whereas 4-DAMP did not produce any significant effect
(P 
 
  
 
0.05), as could be expected when the two receptors,
M
 
3 
 
and M
 
4
 
, which exhibit reciprocal effects on KC migra-
tion, are blocked simultaneously (Fig. 1 D).
To elucidate the role of mAChRs in regulation of KC mi-
gration speed, we used a scratch assay that measures pre-
dominantly linear migration (Savani et al., 1995). The re-
sults obtained through both assays were always coherent.
 
Effects of M
 
3 and M4 mAChR gene KO on KC migration 
in vivo and in vitro
1-cm
2 excisional wounds were inflicted in the back skin of
M3
   , M4
   , and wild-type (WT) mice. The mice were
killed 3, 5, 7, or 10 d later, and the rate of epithelializa-
tion was assessed in specimens of wound tissue stained with
hematoxylin and eosin. The representative images used for
quantitative histomorphometry, illustrating the time course of
wound reepithelialization, are shown in Fig. 2 A. The mor-
Figure 2. Effects of mAChR gene KO 
on crawling locomotion of murine KCs. 
(A) The representative images of wound 
tissue of WT and mAChR KO mice harvested 
on the third and fifth day after wounding. 
The edge of the full thickness wound 
extending from the epidermis down to the 
dermis is depicted by arrowheads. The 
direction of forward movement of the epi-
thelial tongue from the excision site (arrow) 
is indicated with a dotted line with an 
arrowhead. Bar, 150  m. Insets show 
immunolocalization of M3 and M4 on the 
epithelial tongues of M4
    and M3
    mice, 
respectively, on the fifth day after wounding. 
Bar, 20  m. (B) Alterations in epithelial-
ization rate of skin wounds in M3
 /  and 
M4
    mice. The data are means   SD of 
the rate of epithelialization computed in six 
M3
    and M4
    mice compared with that 
determined in six WT animals, taken as 
100%. *, significant (P   0.05) differences 
from the epithelization rate in WT mice. #, 
P   0.05. (C) Representative images of hair 
follicles in the skin of 1-d-old WT and 
mAChR KO mice. An apparent stage of 
morphogenesis is shown as numbers under-
neath each hair follicle. Hematoxylin and 
eosin staining of cryostat sections of the
longitudinal sections harvested from the 
upper back skin. Bar, 50  m. (D) Quantitative 
morphometric analysis of hair follicle devel-
opment in mAChR KO mice. The percentage 
of hair follicles in each stage of morpho-
genesis (x axis) was determined in 1-d-old 
WT, M3
   , and M4
    mice. (E) Alterations 
of migration rate of KCs from M3
    and M4
    
mice in AGKOS plates. The results are means   SD of the migration distance of intact WT KCs (taken as 100%). *, significant (P   0.05) differences 
from the migration distance of WT KCs; #, significant (P   0.05) differences from the migration distances of nontreated KCs in each subgroup.264 The Journal of Cell Biology | Volume 166, Number 2, 2004
phometric analysis revealed that on the third day after wound-
ing, M3
     mice exhibited a small increase (P    0.05),
whereas M4
    mice showed a significant (P   0.05) decrease
of epithelialization rate (Fig. 2 B). These changes became
more pronounced on the fifth day after wounding, when the
epithelialization rate in M3
    mice increased by  60% (P  
0.05) and that in M4
    mice decreased by  50% (P   0.05).
To eliminate possible confounding effects of proliferation
and apoptosis on the measurements of epithelialization rate
through morphometric analysis, both proliferating and ap-
optotic KCs were visualized within the epithelial tongues cov-
ering the wounds using antibody to the proliferation marker
Ki-67 and the TUNEL technique, respectively. We found
no statistical differences (P   0.05) between the numbers of
positive cells among the mutant and WT mice. In each
strain, the Ki-67–positive KCs constituted  10% of total
cells seen in a microscopic field at the magnification of 10,
and that of TUNEL-positive KCs never exceeded 5%.
Taken together, these data indicated that the early stage of
wound epithelialization, mediated by crawling locomotion
of KCs (Woodley et al., 1993), was facilitated in the absence
of M3 and delayed in the absence of M4 receptors.
To elucidate differences in hair follicle morphogenesis, a
physiological process where massive KC migration occurs,
we performed quantitative morphometric analysis of hair
follicle development in mAChR KO mice. 1-d-old M3
   
pups displayed accelerated hair follicle morphogenesis, as
could be judged from a significantly (P   0.05) increased
number of hair follicles in advanced stages of perinatal folli-
cle morphogenesis (stages 6–8) and a reciprocal decrease of
the percentage of follicles at the early stages of their develop-
ment (stages 1–3) compared with WT controls (Fig. 2, C
and D). In marked contrast, the M4
    neonates showed a
retardation of hair follicle morphogenesis evidenced by a sig-
nificant (P   0.05) increase in the number of hair follicles at
the immature developmental stages and a corresponding re-
duction of the percentage of hair follicles at more mature
stages (Fig. 2, C and D).
The roles of M3 and M4 mAChRs in regulating KC crawl-
ing locomotion were further investigated in AGKOS plates
loaded with KCs grown from the epidermis of WT and
M3
 /  and M4
 /  mutant mice. As expected, the lack of M3
receptors was associated with an increase of KC migration
distance by  85% (Fig. 2 E). The M4
 /  KCs showed a sig-
nificantly reduced migration distance (by  50%; P  
0.05). 10 nM of the M4-preferring antagonist MT3 signifi-
cantly (P   0.05) decreased the migration distances of M3
 / 
KCs, but had no effects on the migration distance of M4
 / 
cells (not depicted). 10 nM 4-DAMP increased the migra-
tion distance of M4
 /  KCs compared with nontreated M4
 / 
cells (P   0.05).
Role of intracellular-free calcium ([Ca
2 ]i) in the 
signaling pathways mediating reciprocal effects 
of M3 and M4 on KC migration
Because elevation of [Ca
2 ]i can mediate both M3 (Carroll
and Peralta, 1998) and M4 (Ransom et al., 1991) signaling,
we sought to determine if the inhibitors of Ca
2  ATPase in
endoplasmic reticulum with thapsigargin or cyclopiazonic
acid alter the stimulatory effect of siRNA-M3 and the inhibi-
tory effect of siRNA-M4 on KC migration. The siRNA-M3–
or siRNA-M4–transfected versus intact KCs were exposed to
either 1  M thapsigargin (Fig. 3) or 20  M cyclopiazonic
acid (not depicted) dissolved in KGM for 30 min daily dur-
ing the 10-d duration of the migration assay in AGKOS
plates. Mobilization of [Ca
2 ]i produced a mild inhibitory
effect on migration distance of intact KCs (P   0.05), abol-
ished an up-regulated migration of siRNA-M3–transfected
KCs (P   0.05), decreasing it slightly below the normal
level (P   0.05), and produced no significant alterations
of the down-regulated migration of siRNA-M4–transfected
cells (P   0.05).
Role of the GC–cGMP–PKG pathway in the mechanism 
of M3-dependent inhibition of KC migration
Among the known signaling mechanisms engaged upon M3-
dependent mobilization of [Ca
2 ]i, a possible role for the
PKC-dependent pathway in mediating the inhibitory effect
of M3 on KC migration has been ruled out by the results
showing that although activation of M3 inhibits cell migra-
tion, the direct activation of PKC with phorbol 12-myristate
13-acetate actually stimulates migration (Varker and Wil-
liams, 2002). Therefore, we investigated the role of the
cGMP cascade, which is an alternative pathway that can be
engaged in the muscarinic signaling upon mobilization of
[Ca
2 ]i (Michikawa et al., 1998). Treatment of intact or
thapsigargin-pretreated KCs with 10  M of the GC inhibi-
tor LY-83,583, significantly (P   0.05) up-regulated KC
migration (Fig. 3). These results indicated that the GC-
dependent activation of cGMP cascade is engaged in the sig-
naling pathway linking M3 to inhibition to KC migration
downstream from the [Ca
2 ]i mobilization step. This hy-
pothesis was tested in an AGKOS assay in which the siRNA-
M3–transfected KCs were incubated in the presence of 5
 M of the cGMP analogue 8-pCPT-cGMP, which signifi-
cantly (P   0.05) decreased an up-regulated migration dis-
tance of siRNA-M3–transfected KCs (P   0.05). Because
8-pCPT-cGMP is a selective activator of PKG type I , I ,
and II (Sirotkin et al., 2000), we tested a role for the PKG-
mediated signaling pathway downstream from M3-depen-
dent cGMP production. PKG was irreversibly blocked with
the selective inhibitor of PKG type I and II Rp-8-pCPT-
cGMP (Butt et al., 1994). In the presence of 1  M Rp-8-
pCPT-cGMP, intact KCs migrated significantly (P   0.05)
farther than nontreated control cells. However, this up-regu-
lated migration could be abolished by 10  g/ml C3 exoen-
zyme as well as by 5  M of the ROK inhibitor Y-27632
(Fig. 3). These findings indicated that in the signaling cas-
cade linking M3 to inhibition of KC migration, the PKG ac-
tivation step is situated proximally to the interception with
the RhoA–ROK pathway maintaining KC migration.
Role of the AC–cAMP–PKA pathway in the mechanism 
of M4-dependent stimulation of KC migration
The immediate effect of M4 activation is inhibition of AC con-
stitutively activated through Gs-coupled receptors, such as KC
 2 adrenergic receptors stimulated by autocrine epinephrine
(Schallreuter, 1997). Activation of the cAMP signaling cascade
is associated with inhibition of migration of various cell types
(Johnson et al., 1972; McCawley et al., 2000). Hence, theMuscarinic control of keratinocyte migration | Chernyavsky et al. 265
functional inactivation of M4 that decreased KC migration
could result from the inhibitory action of a Gs-coupled signal-
ing pathway released from the M4 control by MT3 and siRNA-
M4. The AC inhibitors up-regulated migration of siRNA-M4–
transfected KCs (P   0.05), indicating that AC, rather than
[Ca
2 ]i, plays a key role in the M4-coupled signaling pathway.
To elucidate the mechanism of M4  signaling in KCs
downstream from inhibition of AC, we tested the effect of
the cAMP analogue Sp-8-Br-cAMPS, which decreased the
migration distance (P   0.05; Fig. 3), suggesting further
that M4 stimulates KC migration by putting a brake on the
signaling pathway that includes the cAMP activation step.
Because Sp-8-Br-cAMPS, just like naturally occurring cAMP,
exhibits its biological action via activation of PKA (Seebeck
et al., 2002), we sought to determine the role for PKA in the
signaling pathway linking M4 to KC migration. 25 nM of
the PKA inhibitor KT5750 increased the migration distance
of siRNA-M4–transfected KCs to the normal level (P  
0.05; Fig. 3). C3 exoenzyme and Y-27632 inhibited the mi-
gration of both of the KT5750-pretreated and siRNA-M4–
transfected KCs, indicating that in the signaling cascade
linking M4 to stimulation of KC migration, the Rho–ROK
pathway is situated distally from the cAMP-dependent
events.
Relationship between the M3- and M4-coupled 
pathways of the physiologic regulation 
of KC migration by ACh
We tested the effect of 10 nM of the M4 blocker MT3 on
the migration distances of KCs pretreated with Rp-8-pCPT-
cGMP or KT5750. As seen in Fig. 3, although MT3 signifi-
cantly (P   0.05) decreased the migration distance of Rp-
8-pCPT-cGMP–pretreated cells, it had no effect on the
KT5750-pretread KCs. Thus, when the M3-dependent inhi-
bition of migration was blocked pharmacologically or due to
the M3 gene silencing, crawling locomotion of KCs was up-
regulated owing to their unopposed stimulation through the
M4-coupled stimulatory pathway.
Effects of mAChR siRNAs on the integrin expression 
levels in human cultured KCs
Transfection of human foreskin KCs with siRNA-M3 re-
sulted in a decrease of the relative amounts of  2 and  3 in-
tegrins by  50 and 40%, respectively (P   0.05), and an
increase in  5,  v, and  5 expression by  30, 100, and
70%, respectively (P   0.05; Fig. 4). KCs transfected with
siRNA-M4 showed changes in the integrin expression pat-
tern that were, in most cases, reciprocal to those observed in
KCs transfected with siRNA-M3, suggesting that knock-
down of M3 receptors favors the expression of the migratory
integrins, whereas the silencing of M4 receptors leads to
overexpression of sedentary integrins.
Signaling mechanisms leading to integrin switch 
in human cultured KCs
We measured integrin expression in KCs migrated for 10 d
in AGKOS plates in the presence of the PKG inhibitor Rp-
8-pCPT-cGMPS and compared it with that in KCs exposed
to Rp-8-pCPT-cGMPS only for 6 h, during which no ap-
preciable migration can occur (Grando et al., 1993b). KCs
Figure 3. Effects of the mAChR signaling modifiers on migration of human KCs. The migration assays of intact or siRNA-M3– or siRNA-M4–
transfected KCs were performed in AGKOS plates. The cells were exposed to 1  M thapsigargin (TG), 10  M LY-83,583 (LY), 1 mM SQ 
22536 (SQ), 50  M Sp-8-Br-cAMPS (Sp), 5  M 8-pCPT-cGMP (8p),1  M Rp-8-pCPT-cGMPS (Rp), 25 nM KT5720 (KT), 10  g/ml C3 exoenzyme 
(C3), 5  M Y-27632 (Y), or 10 nM MT3 dissolved in KGM. Some cells were pretreated for 30 min with thapsigargin, Rp-8-pCPT-cGMPS, 
or KT5720 before exposing them to a second test agent versus no additional (NA) treatment. The results are expressed as means   SD of 
nontreated control, taken as 100%. *, significant (P   0.05) differences from control. Significant differences between specific experimental 
conditions are indicated in the graph with square brackets with arrows.266 The Journal of Cell Biology | Volume 166, Number 2, 2004
exposed to Rp-8-pCPT-cGMPS for 10 d showed reciprocal
changes in the expression of the migratory and sedentary in-
tegrins, which included both a decrease of the relative
amount of  2 and  3 by  45 and 55%, respectively, and
an increase of  5,  v, and  5 by approximately, 280, 300,
and 320%, respectively (P   0.05). However, significant
changes in the integrin expression pattern, featured by an
up-regulated expression of the migratory integrins  5,  v,
and  5 (P   0.05), could be seen already after 6 h of expo-
sure (Fig. 4). The shifts in the integrin expression pattern
were abolished when KCs were exposed to Rp-8-pCPT-
cGMPS in the presence of the M4 inhibitor MT3 (Fig. 4).
Thus, a decrease of the sedentary integrin expression after
10 d of incubation might be secondary to outside-in signal-
ing occurring in actively moving KCs (Longhurst and Jen-
nings, 1998). The rapid shift in the integrin expression after
6 h of incubation suggested that signaling from M4 up-regu-
lates the migratory integrin gene expression, thus launching
crawling locomotion of KCs.
To elucidate the role of PKA in the KC integrin shift, the
cells were exposed for 6 h or 10 d to the PKA inhibitor
KT5750, M4 antagonist MT3, or a combination of both.
The short-term exposure produced no significant changes in
the integrin phenotype (P   0.05; Fig. 4). After the long-
term incubation, which provided for KC migration, the cells
exposed to KT5750 demonstrated slightly increased levels of
the migratory integrins  5,  v, and  5, which could be a re-
sult of the outside-in signaling characteristic of crawling
KCs. The effect of a long-term exposure to MT3 was very
similar to that of transfection with siRNA-M4 (Fig. 4) and
included both up-regulation of the sedentary integrins  2
and  3, and down-regulation of the migratory integrins  5,
 v, and  5 (P   0.05), which is consistent with migration
inhibition by both MT3 and siRNA-M4 (Fig. 1 D). The
cells exposed to both KT5750 and MT3 for 10 d had a de-
creased level of  3 and increased levels of  5 and  5 (P  
0.05; Fig. 4).
Role of integrins in altered KC migration 
in mAChR KO mice
In WT mice, wounding down-regulated the expression of
the sedentary integrins  2 and  3 in WT mice, as detected by
Western blotting (Fig. 5 A) and semiquantitative IF (Fig. 5
B). In marked contrast, the protein levels of the migratory
integrins  5,  v, and  5 in wounded skin exceeded those
found in the intact skin. In M3
    mice, the relative expres-
sion levels of all sedentary integrins were decreased in both
intact and wounded skin, whereas those of migratory inte-
grins were increased compared with WT mice (Fig. 5, A and
B). In M4
    mice, the relative amounts of the sedentary in-
tegrins  2 and  3 were found to be significantly (P   0.05)
increased in the intact skin by both Western blotting and IF.
Although wounding down-regulated expression of the sed-
entary integrins and up-regulated  5 and  V expression, the
 5 integrin levels were found to be below the control values
in samples from both intact and wounded skin (Fig. 5, A
and B). Although the relative amounts of the integrins under
consideration in KCs residing in the epithelial tongues of
Figure 4. Muscarinic effects on integrin expression in human KCs. Relative amounts of  2,  3,  5,  V, and  5 integrins were analyzed by 
Western blotting of total protein isolated from human KCs 72 h after transfection with siRNA-M3, siRNA-M4, or negative control siRNA 
(siRNA-NC), and from control KCs treated with TransIT-TKO transfection reagent mixed in Opti-MEM medium alone (control). Changes in the 
expression of integrins in human cultured KCs treated with mAChR signaling modifiers were similarly analyzed after incubation for 6 h or 10 d 
in the absence (control) or presence of 1  M Rp-8-pCPT-cGMPS (Rp), 25 nM KT5720 (KT) or 10 nM MT3, or a combinations of these agents 
shown in the table. The images show typical bands appearing at the expected molecular weights (MW). *, significant (P   0.05) differences 
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WT versus mAChR KO mice were different, the immuno-
staining patterns were similar (Fig. 5 C).
We performed an additional series of experiments using sin-
gle cell–type cultures of murine KCs from the epidermis of
neonatal M3
   , M4
   , and WT mice. While M3
    KCs fea-
tured decreased amounts of sedentary integrins and increased
amounts of migratory integrins, the M4
 /  KCs exhibited in-
creased expression of sedentary integrins and decreased expres-
sion of migratory integrins (Fig. 5 A and Table I).
Next, we tested the effects of mAChR null mutations on
the ability of receptor KO KCs to move over the ECM pro-
teins that represent known ligands for the integrin types under
consideration.  v 6 and  5 1 integrin receptors preferentially
bind to fibronectin,  3 1 and  6 4 bind to laminin 5,  2 1
binds to collagen types I and IV, and  5 5 binds to vitronectin
(for review see Yamada et al., 1996). Compared with migra-
tion of WT KCs over fibronectin and vitronectin, the migra-
Figure 5. Role of integrins in mediating effects of M3 and M4 mAChRs on KC migration in vivo and in vitro. (A) Western blotting analysis of 
integrin gene expression. Equal samples of normal (N), i.e., intact, and wound (W) tissues were harvested from two wounds inflicted in six 
mice of each subgroup 24 h after wounding. Monolayers of murine KCs were established from the skin of neonatal WT and M3
    and M4
    
mutant mice, and grown to  70% confluence in KGM. The results are expressed as ratios of the densitometry value of each integrin to that of 
 -actin in the same lane, compared with the values obtained in either intact skin or KCs grown from WT mice (taken as 1). (B) Semiquantitative 
IF analysis of KC integrin expression in the skin of WT and M3
    and M4
    mutant mice. Cryostat sections of intact and wounded skin from 
killed mice were stained with the antibodies targeting integrins indicated on the x axis. Fluorescence intensities of normal (intact) and wounded 
skin in the KO mice are expressed relative to levels determined in the intact and wounded skin, respectively, of WT mice (taken as 100%). 
Data are means   SD from experiments performed with the tissue from two wounds in each of six mice in each subgroup. All changes are 
statistically significant (P   0.05). (C) Immunolocalization of integrin receptors in KCs comprising the epithelialization tongue of WT mice 
on the third day after wounding. Bar, 25  m. (D) Effects of the mAChR gene null mutation on the ability of murine KCs to migrate over ECM 
proteins. The migration distance was measured using a scratch assay. The M3
    and M4
    versus WT (control) KCs were freshly seeded in the 
culture dishes either uncoated (uc) or coated with fibronectin (fn), vitronectin (vn), laminin (lm), collagen I (cI) or IV (cIV), and the formed 
monolayers were wounded with a 100- l pipette tip. The amount of migration was quantitated, and the results were expressed relative to 
migration distance of WT KCs (taken as 100%). (E) Effects of antiintegrin antibodies on migration distance of mAChR KO and WT KCs. The 
migration distance was measured using a scratch assay. The M3
    and M4
    KCs were grown to confluence in uncoated culture dishes, and 
the monolayers were wounded with a 100- l pipette tip and incubated with (experiment) or without (control) antibodies targeting integrins 
identified on the x axis. The amount of migration was quantitated, and the results were expressed relative to migration distance of control KCs 
(taken as 100%). (A, D, and E) Asterisks indicate significant (P   0.05) differences from control.
tion of M3
 /  KCs was significantly (P   0.05) up-regulated
and that of M4
 /  KCs was down-regulated (Fig. 5 D).
Finally, the role for integrins in providing a mechanistic
link between M3 and M4 mAChR signaling pathways and
crawling locomotion was investigated by measuring the rate
of reepithelialization of in vitro wounds in the monolayers of
WT and mutant KCs in the presence or absence of a specific
anti-integrin antibody. Compared with WT KCs, the mi-
gration of M3 KO cells was significantly (P   0.05) reduced
in the presence of antibodies to migratory integrins, and that
of M4 KO cells was reduced in the presence of antibodies to
sedentary integrins (Fig. 5 E).
Discussion
We demonstrated for the first time that M3 and M4 mAChRs
exhibit reciprocal effects on the lateral migration of KCs. Ac-268 The Journal of Cell Biology | Volume 166, Number 2, 2004
tivation of M3 receptors inhibited KC migration and led to
the preferential expression of sedentary integrins. On the
other hand, activation of M4 receptors stimulated KC migra-
tion and favored the expression of migratory integrins. The
inhibitory effect of M3 was mediated through the [Ca
2 ]i-
dependent GC–cGMP–PKG signaling pathway. The M4
effects resulted from inhibition of the inhibitory pathway
involving the AC–cAMP–PKA pathway. Both muscarinic
signaling pathways intersected at Rho, indicating that ROK
provides a common effector mechanism for regulation of cell
migration by ACh through M3 and M4 mAChRs.
In this study, we observed a pronounced inhibition of KC
crawling locomotion with the M4 receptor–selective blocker
MT3 (Jolkkonen et al., 1994). Moreover, the pivotal role of
M4 receptors in facilitating KC crawling locomotion was
convincingly demonstrated in experiments in which M4 re-
ceptor expression was either knocked down with siRNA or
completely abolished in transgenic M4
 /  mice. Studies with
anti-M3 siRNA and M3
 /  mice demonstrated that reduced
or absent signaling through M3 receptors increases KC mi-
gration. Although the siRNA-M3 and siRNA-M4 used in this
study specifically inhibited M3 and M4 expression, respec-
tively, this technology does not allow permanent gene silenc-
ing. Hence, the changes in the migration distances observed
in transfected cultures might represent the initial reduction
in the M3 and M4 levels.
Because stimulation of migration of siRNA-M3–trans-
fected KCs could be suppressed with the M4 receptor–pre-
ferring antagonist MT3, the elimination of the inhibitory
M3 receptor activity apparently unmasked the stimulatory
activity of M4 receptors on the KC migratory function. It is
well documented that other signaling molecules, such as
growth factors, also play important roles in stimulating KC
migration. Therefore, not surprisingly, compared with WT
and M3
 /  mice, the epithelialization of M4
 /  mice was sig-
nificantly delayed, but not completely blocked, as it would
occur if M4 was the only signaling pathway regulating migra-
tion in KCs. The fact that wound epithelialization was sig-
nificantly different 3–5 d after wounding reflects differences
in KC migration because reepithelialization is predomi-
nantly mediated by the migratory function of KCs (Wood-
ley, 1996).
In human epidermis, M4 receptors are predominantly ex-
pressed by the lowermost prickle cells that continuously mi-
grate upward, whereas terminally differentiated KCs lack M4
receptors (Nguyen et al., 2001). In marked contrast, M3 re-
ceptors are predominantly expressed by basal KCs that es-
tablish hemidesmosomal contact with the basal membrane
(Ndoye et al., 1998). Hence, M3 receptor–induced down-
stream signaling may support the establishment and/or
maintenance of stable connections of KCs with the substrate
in culture, and of the epidermis to the underlying dermis in
the skin. It has been proposed that activation of M3 receptors
is coupled to both up-regulation of  1 integrin–mediated
cell adhesion (Quigley et al., 1998; Williams, 2003) and in-
hibition of cell migration (Varker and Williams, 2002).
Therefore, the stimulation of KC migration caused by sup-
pression of M3 receptor signaling might be mediated by
decreased attachment of KCs to ECM proteins, such as
laminin, which are known to decrease crawling locomotion
(Decline and Rousselle, 2001).
The mechanism of muscarinic regulation of KC motility
characterized in this study is schematically shown in Fig. 6.
GPCRs play an important role in mediating biological ef-
fects of different hormones, growth factors, cytokines, and
cytotransmitters on cell motility. Cell migration can be in-
creased by activating a variety of heterotrimeric GPCRs, in-
cluding those for adenosine (Woodhouse et al., 1998),
angiotensin II (for review see Demoliou-Mason, 1998),
lysophosphatidic acid (Lummen et al., 1997), opioids (Arai
et al., 1997), sphingosine 1-phosphate (Graeler and Goetzl,
2002), thrombin (Arai et al., 1997; Lummen et al., 1997),
and various peptide chemoattractants and cytokines (for
review see Arai et al., 1997). Some of these GPCRs stimu-
late G q/11, whereas others stimulate G i/o, leading to spe-
cific biological responses (Lummen et al., 1997; for review
see Demoliou-Mason, 1998). For instance, stimulation of
mAChRs in oligodendrocytes activates  v integrin on the
cell surface (Gudz et al., 2002).
The opposing effects of M3 and M4 receptor activation on
KC migratory function were mirrored by reciprocal changes
in the integrin gene expression patterns. An M4-dependent
shift in the integrin phenotype to a migratory pattern might
be sufficient to launch KC crawling locomotion. On the
other hand, a shift toward the sedentary phenotype in the
KCs with inactivated M4 activity is probably a secondary
phenomenon, resulting from an outside-in signaling mecha-
nism operating in a slowly migrating KC. It has been dem-
onstrated that phosphorylation of paxillin and focal adhe-
sion kinase by activation of M3 receptors is dependent on
the outside-in signaling downstream from integrin receptor
binding to the ECM ligand (Rosado et al., 2000).
Results of this study strongly suggest that elevation of
[Ca
2 ]i plays a role in the signaling cascade linking M3 to in-
hibited KC migration and that this cascade involves ac-
tivation of the cGMP-dependent pathway. GC activation
is mediated via an M3 mAChR coupled to a pertussis
toxin–insensitive G protein, whereas the GC inhibition can
result from a pertussis toxin–sensitive Gi/o protein–coupled
mAChR (Tonnaer et al., 1991; Alfonzo et al., 1998). We
have demonstrated previously that activation of M4 receptors
results in a decrease in [Ca
2 ]i, whereas activation of M3 re-
ceptors increases Ca
2  in KCs (Nguyen et al., 2001), and
that a nicotinic ACh receptor–mediated increase of [Ca
2 ]i is
Table I. Summary of changes of integrin gene expression in mAChR 
KO versus WT mice
M3
    M4
   
In vivo (IF) In vitro (WB) In vivo (IF) In vitro (WB)
Integrin N W N W
 2 ↓
a ↓
a ↓↑
a ↑↑
a
 3 ↓
a ↓
a ↓
a ↑
a ↑↑
 5 ↑
a ↑
a ↑↓
a ↑
a ↓
a
 V ↑
a ↑
a ↑
a ↓
a ↑
a ↓
a
 5 ↑
a ↑
a ↑
a ↓
a ↓
a ↓
IF, immunofluorescence; N, normal (intact) skin; W, wound tissue; WB,
Western blot.
aP   0.05 and the rest are P   0.05 compared to WT mice.Muscarinic control of keratinocyte migration | Chernyavsky et al. 269
associated with decreased migration of human KCs in AG-
KOS (Zia et al., 2000).
To address a possibility that the two types of mAChRs,
M3 and M4, exhibit reciprocal control of KC migration ow-
ing to competition of their effectors for common regulators
of cell motility, Rho and ROK, we studied the effects of Rho
and ROK inhibitors on the migration of intact and siRNA-
M3– or siRNA-M4–transfected KCs in AGKOS plates. The
obtained results indicate that regulation of the Rho–ROK
pathway is a common endpoint in the signaling mechanism,
mediating muscarinic control of KC migration. Because
cAMP inhibits activation of Rho (Gratacap et al., 2001),
mostly owing to its PKA-dependent phosphorylation (Dong
et al., 1998), one of the mechanisms mediating the stimula-
tory effect of M4 signaling on KC migration, in addition to
inactivation of GC, could be inhibition of the cAMP cas-
cade resulting in PKA activation. This supposition was
corroborated by the ability of the PKA inhibitor KT5750
to reverse inhibited migration of siRNA-M4–transfected or
MT3-treated KCs. Thus, the stimulatory effect of M4 on KC
migration stems from M4-dependent inhibition of AC acti-
vation through a G s protein coupled by one of the KC
GPCRs that are known to inhibit KC migration, such as
 2-adrenergic receptors that can inhibit KC migration via
 2-adrenergic receptor–mediated elevation of cAMP (Don-
aldson and Mahan, 1984).
In conclusion, the available data indicate that KC migra-
tion is regulated by ACh through both stimulatory and in-
hibitory signaling pathways, involving different populations
of cell surface ACh receptors. The diversity of ACh receptors
expressed by KCs in the course of their maturation would al-
low ACh to exert different effects at various stages of cell de-
velopment. We propose that simultaneous stimulation of KC
M3 and M4 receptors by endogenously secreted ACh is re-
quired to synchronize the development of ionic and meta-
bolic events in migrating KCs. These findings offer novel
mechanistic insights underlying the cholinergic control of
KC crawling locomotion. They also suggest that mAChR-selec-
tive drugs and siRNA may serve as novel tools to modulate
abnormal KC migration, such as in wounds that fail to heal.
Materials and methods
Chemicals and tissue culture reagents
The muscarinic receptor blocker 4-DAMP was purchased from Sigma-
Aldrich. The M4 inhibitor MT3 was prepared as detailed elsewhere (Karls-
son et al., 2000). Cell permeable inhibitors of Ca
2 -ATPases cyclopiazonic
acid and thapsigargin, competitive inhibitor of GC LY-83,583, irreversible
inhibitor of AC MDL-12,330A, membrane permeant, selective inhibitor of
PKG 1a, 1b and type II Rp-8-pCPT-cGMPS, selective inhibitor of PKA
KT5720, membrane permeant cAMP and cGMP agonists Sp-8-Br-cAMPS
and 8-pCPT-cGMP, respectively, functional inhibitor of Rho proteins C3
exoenzyme, and cell-permeable and selective inhibitor of ROK Y-27632
were purchased from Axxora, LLC, whereas the cell-permeable AC inhibi-
tor SQ 22536 was from Calbiochem-Novabiochem. KGM containing 5 ng/
ml of epidermal growth factor and 50  g/ml of bovine pituitary extract
were purchased from GIBCO BRL. Agarose type A was obtained from Ac-
curate Chemical & Scientific Corporation. Heat-inactivated newborn calf
serum, 0.05% trypsin, trypan blue dye solution, and Wright’s stain were
obtained from Sigma-Aldrich. Rabbit polyclonal antibodies to  2,  3,  5,
 v, and  1 integrins were purchased from Chemicon International, Inc.
Anti– -actin antibody and secondary, FITC-labeled goat anti–rabbit anti-
bodies were from Sigma-Aldrich. The antibodies to M3 and M4 mAChRs
that we characterized previously (Ndoye et al., 1998) are commercially
available from Research and Diagnostic Antibodies. Rat anti–mouse anti-
body to the proliferation marker Ki-67 and a secondary, FITC-conjugated
antibody were purchased from DakoCytomation. The DeadEnd
TM Fluoro-
metric TUNEL System allowing visualization of apoptotic KCs was pur-
chased from Promega.
mAChR mutant mice
Mice deficient in M3 or M4 mAChRs (M3
 /  and M4
 /  mice, respectively)
were generated as described previously (Gomeza et al., 1999; Yamada et
al., 2001). In all experiments, age- and gender-matched WT mice of the
Figure 6. Hypothetical scheme of the 
signaling mechanisms linking M3 and M4 
to regulation KC motility and integrin 
expression. The signaling cascades originating 
at M3 and M4 include distinct stimulatory 
(→) and inhibitory (•••) steps and converge 
at the common effector pathway involving 
Rho proteins.270 The Journal of Cell Biology | Volume 166, Number 2, 2004
same genetic background (129/SvEv   CF1) were used as controls. Mouse
genotyping was performed by PCR analysis of mouse tail DNA.
Cultures of human and murine KCs
Human KCs were isolated from foreskin epidermis and grown in culture as
detailed elsewhere (Grando et al., 1993a). Murine KCs were similarly iso-
lated from the epidermis of WT and M3
 /  and M4
 /  mutant mice that
were 1–2 d old and grown using the cell culture techniques optimized for
mouse KCs (Arredondo et al., 2002).
siRNA preparation and KC transfection
To design target-specific siRNA duplexes, we selected sequences of the
type AA (N19) UU (N, any nucleotide) from the open reading frame of the
target mRNAs to obtain a 21-nt sense and 21-nt antisense strand with sym-
metric 2-nt 3  overhangs of identical sequence (Elbashir et al., 2001). The
siRNA-M3 and siRNA-M4 were custom synthesized by Dharmacon. The
target sequences for the human CHRM3 (NM_000740) and CHRM4
(NM_000741) genes were as follows: CHRM3, 5 -GGTCAACAAGCAGCT-
GAAG-3   (corresponding to amino acids 280–300); and CHRM4, 5 -
CCTCTACACCGTGTACATC-3  (corresponding to amino acids 259–279).
The negative control siRNA-targeting luciferase gene was also purchased
from Dharmacon. For transfection, human KCs were seeded at a density of
5   10
4 cells per well of a 24-well plate, and incubated for 16–24 h to
achieve  70% confluence. To each well, increasing concentrations (see
Results) of siRNA duplex in the transfection solution were added, and the
transfection was continued for 16 h at 37 C in a humid, 5% CO2 incubator.
On the next day, the transfection medium was replaced by KGM, and the
cells were incubated for 72 h to achieve maximum inhibition of mAChR
protein expression. After 72 h of incubation, the cells were harvested and
the proteins were extracted and used in Western blotting assays of integrin
expression. The siRNA transfection efficiency in KCs was also assayed us-
ing FITC-labeled luciferase GL2 duplex (Dharmacon) with the target se-
quence 5 -CGT ACG CGG AAT ACT TCG A-3 .
In vitro KC migration assays
AGKOS assay. Second passage human or murine KCs were suspended in
KGM, counted in a hemocytometer, loaded at a high density (4   10
4
cells/10  l) into each 3-mm well in an agarose gel, and used in AGKOS as-
says as detailed elsewhere (Grando et al., 1993b; Zia et al., 2000). KCs
were fed with KGM containing various concentrations of cholinergic drugs
or no drugs (control), and incubated for 10 d in a humid CO2 incubator
with daily changes of medium. Some human KCs were first transfected
with siRNA, and then exposed to drugs. To standardize results obtained in
experiments using KCs from different donors, the mean values of the mi-
gration distances were converted into the percentage of control. The con-
trol value for KCs from each particular donor was determined by measur-
ing the baseline migration distance (in millimeters) and taken as 100%. In
parallel studies, to control for changes in the rate of KC proliferation on the
migration distances measured by AGKOS assay, we exposed KCs in AG-
KOS plates to test compounds in the presence of 10  g/ml of the growth-
arresting agent mitomycin C (Sigma-Aldrich).
Scratch assay. The original scratch assay (Savani et al., 1995) was
adapted to measuring KC migration as detailed elsewhere (Cha et al.,
1996). In brief, KCs were either grown to confluence or freshly seeded in
6-well tissue culture dishes. Some dishes were coated with fibronectin,
laminin, collagen I or IV (all from BD Biosciences), or vitronectin (Sigma-
Aldrich). The monolayers were scratched with a 100- l pipette tip and in-
cubated at 37 C and 5% CO2 in air until complete reepithelialization of
wounded monolayers occurred in one of the cultures, but no longer than
24 h. To inhibit proliferation, for the first 2 h of incubation, KCs were fed
with KGM containing 10  g/ml mitomycin C. Reepithelialization was doc-
umented by photography and the amount of migration was quantitated by
computer-assisted image analysis software (IP Lab; Scanalytics). The resid-
ual gap between KCs migrating toward each other from the opposing sides
of the in vitro wound, i.e., the area of the scratch remaining unfilled, was
measured and the results were expressed as percentage of reepithelializa-
tion determined in control, nontreated monolayer. Each experiment was
performed in triplicate.
In vivo wounding and morphometric assay of epithelialization rate
Because the wound healing process is dependent on the stage of the hair
cycle, in each experiment we used the mice of exactly the same age and
gender with hair cycles that were synchronized using the anagen induc-
tion technique (Paus et al., 1990). In brief, 6–7-wk-old WT and M3
 /  and
M4
 /  mutant mice in the state of telogen, as judged by their pink skin
color, were anesthetized and stripped of hair using a wax and rosin mix-
ture that was painted over the back of the mouse and after hardening was
peeled off, inducing the resting follicles to enter anagen. 5 d later, full
thickness excisions through the panniculus carnosus were made on the
anesthetized skin using a uniform square template with a side length of 1
cm. Each animal received two wounds at the symmetric sites of the central
back, 0.5 cm off the vertebral line. Wounds were left undressed and
wounded animals were individually housed under aseptic conditions for 3,
5, 7, and 10 d, after which time the mice were killed by a CO2 overdose.
Equally sized pieces of the wounded and intact skin near the wound were
excised. To optimize the yield of migrating KCs, we always harvested the
wound border by shaving a narrow strip along the perimeter of the wound.
For extraction of total proteins used in Western blotting assay, the pannic-
ulus carnosus was removed (confirmed microscopically), and tissue was
weighed, diced, and sonicated. At least six animals per time point and ge-
notype were used. The morphometric analysis on sections was always per-
formed from the middle of the wound. The rate of epithelialization was as-
sayed in hematoxylin and eosin–stained cryostat sections of the wound
tissue by measuring the lengths of the tongues of new epithelium extend-
ing from either side of the wound, in accordance with standard protocols
of morphometric analysis (Graves et al., 2001). In brief, three to five ran-
dom microscopic fields were captured at a magnification of 4 in each skin
section cut perpendicularly to the edge of the wound. The images were
printed and the rate of epithelialization was computed by measuring di-
rectly on the prints the length of the epithelialization tongue advancing
over the wound bed from its margin, which could be easily identified
based on the abrupt change in the appearance of dermal ground substance
at the excision line (Fig. 2 A). In each image, the length of epidermal out-
growth was measured in millimeters.
Morphometric analysis of hair follicle morphogenesis in mAChR 
KO mice
The morphometric analysis was performed in the longitudinal sections of
dorsal skin of 1-d-old M3
 /  or M4
 /  mice versus WT littermates. The eight
defined substages of hair follicle morphogenesis were identified based on
the criteria defined by Paus et al. (1999). The percentage of hair follicles in
each stage of morphogenesis was assessed using the established technique
detailed elsewhere (Botchkarev et al., 1998). 100 follicles in each of the 50
microscopic fields (at a magnification of 10) of vertical skin sections de-
rived from at least four different animals were calculated in each strain.
IF assay
The IF experiments were performed as detailed previously (Ndoye et al.,
1998), using freshly frozen specimens of intact and wounded murine skin or
cultured KC monolayers as a substrate, and computer-assisted image analy-
sis with a software package purchased from Scanalytics. In tissue samples,
the intensity of fluorescence was calculated pixel by pixel by dividing the
summation of the fluorescence intensity of all pixels by the area occupied
by the pixels (i.e., segment), and then subtracting the mean intensity of fluo-
rescence of a tissue-free segment (i.e., background). For each specimen, a
minimum of three different segments in at least three different microscopic
fields were analyzed. The specimens were examined with a fluorescence
microscope (model Axiovert 135; Carl Zeiss MicroImaging, Inc.).
Western blotting assay
Proteins were isolated by adding 1.5 ml isopropyl alcohol per 1 ml TRIzol
reagent (GIBCO BRL) to the phenol–ethanol supernatant of homogenates
of the samples of human and murine KCs, washed, dissolved in a sample
buffer, separated via 4–15% SDS-PAGE, and electroblotted onto a 0.2- m
nitrocellulose membrane (Bio-Rad Laboratories). The membranes were de-
veloped using a chemiluminescent detection system (ECL Plus; Amersham
Biosciences) and scanned (Storm™/FluorImager; Molecular Dynamics).
The relative density of scanned bands was determined by area integration
using ImageQuant software (Molecular Dynamics), and the results were
expressed as integrated intensity of pixels of the spot excluding the back-
ground. The final results were expressed as ratios of the densitometry value
of each integrin to that of  -actin in the same lane, compared with the val-
ues obtained in control samples. The protein content ratio in each control
sample was always set equal to 1.
Statistics
The results of quantitative experiments were expressed as means   stan-
dard deviation. Significance was determined using Student’s t test.
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